Navigation Links
AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
Date:8/9/2012

REDWOOD CITY, Calif., Aug. 9, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and six months ended June 30, 2012 and provided a development update.

Net loss for the second quarter of 2012 was $7.2 million, or $0.35 per share, compared with a net loss of $4.8 million, or $0.25 per share, for the second quarter of 2011.  Common shares used in calculating basic and diluted earnings per share were 20,627,244 for the second quarter of 2012 compared to 19,374,909 common shares for the second quarter of 2011.

During the second quarter of 2012, AcelRx recognized revenue of $224,000 resulting from reimbursement for work completed under a research grant from the U.S. Army Medical Research and Material Command, or USAMRMC, for development of its ARX-04 product candidate, a Sufentanil NanoTab® for the treatment of moderate-to-severe acute pain. 

Research and development expenses for the quarter ended June 30, 2012 totaled $5.4 million, compared with $3.0 million for the quarter ended June 30, 2011.  The increase was primarily due to expenditures required to conduct two Phase 3 studies for ARX-01, the Sufentanil NanoTab PCA System, AcelRx's lead product candidate for the treatment of post-operative pain. 

General and administrative expenses were $1.8 million for the quarter ended June 30, 2012, compared with $1.6 million for the quarter ended June 30, 2011.  The increase of $0.2 million resulted primarily from expenses associated with commercial market research and patent prosecution efforts.

For the six months ended June 30, 2012, AcelRx reported a net loss of $14.3 million, or $0.71 per sha
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
2. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
3. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
4. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
5. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
6. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
7. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
8. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
9. Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency
10. Isis Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
11. Actinium Pharmaceuticals and Philogen S.p.A. Announce Collaboration for Alpha Therapy Based Antiangiogenesis Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , Sept. 29, 2014 EU5 Capsule Endoscopy ... GlobalData,s new report, "EU5 Capsule Endoscopy Systems ... the EU5 Capsule Endoscopy Systems market. The report provides ... and average prices (in US dollars) within market segments ... Endoscopy Workstations. The report also provides company ...
(Date:9/29/2014)... EU5 Sigmoidoscopes Market Outlook to 2020 ... Market Outlook to 2020", provides key market data ... value, in millions of US dollars, volume (in ... market segments - Flexible Video Sigmoidoscopes and Non-Video ... Sigmoidoscopes). The report also provides company ...
(Date:9/29/2014)... 2014  Following US and European approvals of Elekta,s ... and Drug Administration (CFDA) has cleared the radiation therapy ... According to the International Agency for Research on ... cancer every year in China ... colorectal, liver and esophageal cancers 2 . Versa HD ...
Breaking Medicine Technology:EU5 Capsule Endoscopy Systems Market Outlook to 2020 2EU5 Capsule Endoscopy Systems Market Outlook to 2020 3EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 2Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 3
(Date:9/30/2014)... Seattle, WA (PRWEB) September 30, 2014 ... Intelligence, proudly announced today that the Department of ... Office as its Enterprise End User Business ... to better support our nation’s veterans by enabling ... obtained through BI Office’s powerful enterprise analytics and ...
(Date:9/30/2014)... September 30, 2014 “Biology and ... Bryan W. Brickner, “and it’s about naming rights.” ... Science , new on the Bryan William Brickner ... the National Institutes of Health (PubMed). The post ... sleep disturbances, REM transitions, aging with THC, the ...
(Date:9/30/2014)... A trailblazer at heart, Dr. Scott Katzman stays ... breakthroughs in spine repairs. His newest appreciation has been ... in which he has implanted the Mobi-C Artificial Disc ... art and mimic normal human disc motion. Dr. Katzman goes ... to be an exceptional replacement device for failing fusions. Patients ...
(Date:9/30/2014)... 3M has added four new thin VHB products to ... 5906 , 3M 5907 , 3M 5908 , ... create the strongest bond possible to a wide range of ... difficult surfaces such as paints, low surface energy plastics, and ... are designed specifically for electronic device engineers and electronics manufacturers. ...
(Date:9/30/2014)... RI (PRWEB) September 30, 2014 Dogs are ... Oftentimes, this involves spending time in the car travelling from ... canines have free run of the vehicle; however, this is ... owner as well. Royal Flush Havanese shares with ... always be routine practice. , There are many ways a ...
Breaking Medicine News(10 mins):Health News:U.S. Department of Veterans Affairs Takes Its Analytic Capabilities to the Next Level with BI Office from Pyramid Analytics 2Health News:Homeostasis: Publius’ Sleep Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 3Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 2Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 3
... , The 10th Annual Conference and Exposition of ... Society for Human Resource Management --HR: Building Bridges to Success" in ... July 23-24 , , ... that employee wellness programs that help workers lose weight or quit smoking, for instance, ...
... MUMBAI, July 23 , ... Activity by the Clinical Investigator Dr. A Bhattacharya Working,at the GG ... - Glenmark Not Only Acts as the Whistle-Blower but Also ... After receiving approval from the Drug Controller General of India(DCGI),for ...
... 23 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ), ... and marketing biopharmaceutical,products, today announced that it will release ... after the US market closes on Tuesday,August 11, 2009. ... 3SBio,s senior management will host a,conference call at 5:00 ...
... ... classes. As a special promotion eMindful is offering unlimited classes for the month of ... yoga practice, or has wanted to explore the health benefits of yoga, to participate at ... ...
... ... dentist Dr. Robert L. Williamson one of America,s Top Dentists. , ... Raleigh, North Carolina (PRWEB) July 23, 2009 -- For ... award for being one of the top dentists in the United States. The Consumer,s Research ...
... ... top Orthopedic Surgeons in the greater Atlanta metro area for the second consecutive time. ... skilled, exceptional, and ,most-trusted, sports medicine specialist. , ... Atlanta, GA (PRWEB) July 23, 2009 -- Spero G. Karas M.D. ...
Cached Medicine News:Health News:Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 2Health News:Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 3Health News:Glenmark Brings to the Notice of the Authorities Irregularities of the Clinical Investigator at its Jamnagar Site in Gujarat 2Health News:3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 2Health News:3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 3Health News:eMindful.com Launches Live, Interactive Online Yoga Classes 2Health News:eMindful.com Launches Live, Interactive Online Yoga Classes 3Health News:Dr. Robert L. Williamson III Once Again Selected As One of America's Top Dentists 2Health News:Atlanta Sports Medicine Doctor Spero Karas Wins 'Atlanta's Top Doctors' Honor Again 2Health News:Atlanta Sports Medicine Doctor Spero Karas Wins 'Atlanta's Top Doctors' Honor Again 3
... to add individual components for individual indications. ... indications. Made of an innovative composite plastic ... only much lighter. This means it's easier ... comfortable for the patient. ,Comes pre-assembled, packaged ...
... (iopamidol injection) is a safe and effective ... clinical experience since 1986. Worldwide, more ... been administered. Indicated for a wide ... flexibility by providing a wide range of ...
... agent FDA-approved for administration by power injector, ... contrast media for MR imaging of the ... convenient packaging options for just the right ... delivery. You can trust OptiMARK® for ...
... contrast agent approved for sale in the ... the Amersham Health portfolio to include an ... aids in the detection, localization, characterization, and ... within minutes of injection, and additional scans ...
Medicine Products: